Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Estrogen and Cardiovascular Disease: Is Timing Everything?

Literature DB >> 26110752

Estrogen and Cardiovascular Disease: Is Timing Everything?

Samantha Giordano¹, Fadi G Hage, Dongqi Xing, Yiu-Fai Chen, Steven Allon, Chongjia Chen, Suzanne Oparil.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Estrogens

Year: 2015 PMID： 26110752 PMCID： PMC4490077 DOI： 10.1097/MAJ.0000000000000512

Source DB: PubMed Journal: Am J Med Sci ISSN： 0002-9629 Impact factor: 2.378

× No keyword cloud information.

56 in total

1. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery.

Authors: T Mori; J Durand; Y Chen; J A Thompson; S Bakir; S Oparil
Journal: Am J Cardiol Date: 2000-05-15 Impact factor: 2.778

Review 2. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.

Authors: Linda L Humphrey; Benjamin K S Chan; Harold C Sox
Journal: Ann Intern Med Date: 2002-08-20 Impact factor: 25.391

3. C-reactive protein-mediated vascular injury requires complement.

Authors: Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal: Arterioscler Thromb Vasc Biol Date: 2010-03-25 Impact factor: 8.311

4. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Authors: F Grodstein; J E Manson; G A Colditz; W C Willett; F E Speizer; M J Stampfer
Journal: Ann Intern Med Date: 2000-12-19 Impact factor: 25.391

5. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.

Authors: Andrea Z LaCroix; Rowan T Chlebowski; JoAnn E Manson; Aaron K Aragaki; Karen C Johnson; Lisa Martin; Karen L Margolis; Marcia L Stefanick; Robert Brzyski; J David Curb; Barbara V Howard; Cora E Lewis; Jean Wactawski-Wende
Journal: JAMA Date: 2011-04-06 Impact factor: 56.272

6. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries.

Authors: S Oparil; S J Chen; Y F Chen; J N Durand; L Allen; J A Thompson
Journal: Cardiovasc Res Date: 1999-12 Impact factor: 10.787

7. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.

Authors: G Li; Y F Chen; S S Kelpke; S Oparil; J A Thompson
Journal: Circulation Date: 2000-06-27 Impact factor: 29.690

Review 8. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.

Authors: S Mitchell Harman; Eric Vittinghoff; Eliot A Brinton; Matthew J Budoff; Marcelle I Cedars; Rogerio A Lobo; George R Merriam; Virginia M Miller; Frederick Naftolin; Lubna Pal; Nanette Santoro; Hugh S Taylor; Dennis M Black
Journal: Am J Med Date: 2011-03 Impact factor: 4.965

9. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors: Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal: JAMA Date: 2002-07-03 Impact factor: 56.272

10. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal: JAMA Date: 2002-07-17 Impact factor: 56.272

13 in total

Review 1. Sex differences in cardiovascular ageing.

Authors: Allison A Merz; Susan Cheng
Journal: Heart Date: 2016-02-25 Impact factor: 5.994

2. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation.

Authors: Natalie C Fredette; Matthias R Meyer; Eric R Prossnitz
Journal: J Steroid Biochem Mol Biol Date: 2017-05-18 Impact factor: 4.292

Review 3. Unconventional Estrogen Signaling in Health and Disease.

Authors: Christina L Faltas; Kira A LeBron; Marina K Holz
Journal: Endocrinology Date: 2020-04-01 Impact factor: 4.736

Review 4. Sex Differences in Myocardial and Vascular Aging.

Authors: Hongwei Ji; Alan C Kwan; Melanie T Chen; David Ouyang; Joseph E Ebinger; Susan P Bell; Teemu J Niiranen; Natalie A Bello; Susan Cheng
Journal: Circ Res Date: 2022-02-17 Impact factor: 17.367

5. A hypertension patient-derived iPSC model demonstrates a role for G protein-coupled estrogen receptor in hypertension risk and development.

Authors: Natalie C Fredette; Eliyah Malik; Marah L Mukhtar; Eric R Prossnitz; Naohiro Terada
Journal: Am J Physiol Cell Physiol Date: 2020-08-12 Impact factor: 4.249

6. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.

Authors: Deniz Akdis; Ardan M Saguner; Khooshbu Shah; Chuanyu Wei; Argelia Medeiros-Domingo; Arnold von Eckardstein; Thomas F Lüscher; Corinna Brunckhorst; H S Vincent Chen; Firat Duru
Journal: Eur Heart J Date: 2017-05-14 Impact factor: 29.983

7. Coronary artery calcium is associated with increased risk for lung and colorectal cancer in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors: Omar Dzaye; Philipp Berning; Zeina A Dardari; Martin Bødtker Mortensen; Catherine Handy Marshall; Khurram Nasir; Matthew J Budoff; Roger S Blumenthal; Seamus P Whelton; Michael J Blaha
Journal: Eur Heart J Cardiovasc Imaging Date: 2022-04-18 Impact factor: 9.130